Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial

By Busso Cristiano   Fernndez-Snchez Manuel   Garca-Velasco Juan Antonio   Landeras Jos   Ballesteros Augustn   Muoz Elkin   Gonzlez Sandra   Simn Carlos   Arce Joan-Carles   Pellicer Antonio  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 995-1004

Oxford University Press

Access to resources Recommend Favorite

Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study

By Päkkilä M.  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2211-2214

Oxford University Press

Access to resources Recommend Favorite

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study

By  

ESC HEART FAILURE, Vol. 2, Iss. 1, 2015-03 ,pp. : 5-11

John Wiley & Sons Inc

Access to resources Recommend Favorite